Extracorporeal membrane oxygenation (ECMO) has emerged as an important intervention for children both preceding and following cardiac surgery. There is a notable lack of comprehensive information regarding neurodevelopmental outcomes. The Norwood procedure and complex biventricular repairs exhibit the highest prevalence of ECMO usage. Examination of the data demonstrates that only 50% of ECMO survivors achieved normative cognitive outcomes, with 40% of those experiencing long-term neurological deficits. It is imperative to conduct robustly designed studies with extended follow-up periods to establish guidelines for neuromonitoring and neuroprotection during ECMO in the field of congenital cardiac surgery.
SalvinJWLaussenPCThiagarajanRR. Extracorporeal membrane oxygenation for postcardiotomy mechanical cardiovascular support in children with congenital heart disease. Pediatr Anesth. 2008;18(12):1157-1162.
2.
MascioCEAustinEHJacobsJP, et al.Perioperative mechanical circulatory support in children: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery database. J Thorac Cardiovasc Surg. 2014;147(2):658-665.
3.
SasakiTAsouTTakedaYOnakatomiYTominagaTYamamotoY. Extracorporeal life support after cardiac surgery in children: outcomes from a single institution. Artif Organs. 2014;38(1):34-40.
4.
PadenMLRycusPTThiagarajanRR. Update and outcomes in extracorporeal life support. Semin Perinatol. 2014;38(2):65-70.
5.
FelmlyMLMainwaringRDMartinEMaMHanleyFL. Analysis of risk factors for extracorporeal membrane oxygenation after surgical repair of peripheral pulmonary artery stenosis. JTCVS Open. 2023;13:344-356.
6.
FordMAGauvreauKMcMullanDM, et al.Factors associated with mortality in neonates requiring extracorporeal membrane oxygenation for cardiac indications: analysis of the extracorporeal life support organization registry data. Pediatr Crit Care Med. 2016;17(9):860-870.
7.
AlsoufiBSlesnickTMcCrackenC, et al.Current outcomes of the Norwood operation in patients with single-ventricle malformations other than hypoplastic left heart syndrome. World J Pediatr Congenit Heart Surg. 2015;6(1):9-17.
8.
MerrillEDSchoenebergLSandesaraP, et al.Outcomes after prolonged extracorporeal membrane oxygenation support in children with cardiac disease. J Thorac Cardiovasc Surg. 2014;148(2):582-588.
9.
ShellhaasRAChangTTsuchidaT, et al.The American Clinical Neurophysiology Society's guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol. 2011;28(6):611-617.
10.
MarinoBSLipkinPHNewburgerJW, et al.Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126(9):1143-1172.
11.
BayleyN. The Bayley scales of infant and toddler development. In: BayleyN, ed. The Bayley Scales of Infant and Toddler Development, 3rd ed.Harcourt Assessment, Inc; 2006:99-105.
12.
WechslerD. Wechsler preschool and primary scale of intelligence. In: WechslerD, ed. Wechsler Preschool and Primary Scale of Intelligence, 4th ed.Pearson Assessment, Inc; 2012:126-134.
13.
FallonPAparícioJMElliottMJKirkhamFJ. Incidence of neurological complications of surgery for congenital heart disease. Arc Dis Child. 1995;72(5):418-422.
14.
IJsselstijnHHunfeldMSchillerRM, et al.Improving long-term outcomes after extracorporeal membrane oxygenation: from observational follow-up programs toward risk stratification. Front Pediatr. 2018;6:177.
15.
SadhwaniAChengHStoppC, et al.Early neurodevelopmental outcomes in children supported with ECMO for cardiac indications. Pediatr Cardiol. 2019;40(5):1072-1083.
16.
BrownKLIchordRMarinoBSThiagarajanRR. Outcomes following extracorporeal membrane oxygenation in children with cardiac disease. Pediatr Crit Care Med. 2013(5 Suppl 1):S73–S83.
17.
KaneDAThiagarajanRRWypijD, et al.Rapid-response extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in children with cardiac disease. Circulation. 2010;122(11 Suppl):S241-S248.
18.
RavishankarCDominguezTEKreutzerJ, et al.Extracorporeal membrane oxygenation after stage I reconstruction for hypoplastic left heart syndrome. Pediatr Crit Care Med. 2006;7(4):319-323.
19.
PolitoABarrettCSWypijD, et al.Neurologic complications in neonates supported with extracorporeal membrane oxygenation. An analysis of ELSO registry data. Intensive Care Med. 2013;39(9):1594-1601.
20.
ChrysostomouCMaulTCallahanPM, et al.Neurodevelopmental outcomes after pediatric cardiac ECMO support. Front Pediatr. 2013;1:47.
21.
HamrickSEGremmelsDBKeetCA, et al.Neurodevelopmental outcome of infants supported with extracorporeal membrane oxygenation after cardiac surgery. Pediatrics. 2003;111(6 Pt 1):e671–e675.
22.
CengizPSeidelKRycusPT, et al.Central nervous system complications during pediatric extracorporeal life support: Incidence and risk factors. Crit Care Med. 2005;33(12):2817-2824.
23.
SperottoFCogoPAmigoniAPettenazzoAThiagarajanRRPolitoA. Extracorporeal membrane oxygenation support for failure to wean from cardiopulmonary bypass after pediatric cardiac surgery: analysis of extracorporeal life support organization registry data. Crit Care Explor. 2020;2(9):e0183.
24.
MehtaAIbsenLM. Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med. 2013;2(4):40-47.
25.
PourmoghadamKKOlsenMCNguyenM, et al.Comparative review of outcomes in patients with congenital heart disease requiring cardiopulmonary support for failure to wean from cardiopulmonary bypass or for refractory sudden cardiac arrest. World J Pediatr Congenit Heart Surg. 2015;6(3):387-392.
26.
LequierLJoffeARRobertsonCM, et al.Two-year survival, mental, and motor outcomes after cardiac extracorporeal life support at less than five years of age. J Thorac Cardiovasc Surg. 2008;136(4):976-983.
27.
RyersonLMGuerraGGJoffeAR, et al.Survival and neurocognitive outcomes after cardiac extracorporeal life support in children less than 5 years of age: a ten-year cohort. Circ Heart Fail. 2015;8(2):312-332.
28.
IbrahimAEDuncanBWBlumeEDJonasRA. Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg. 2000;69(1):186-192.
29.
ChowGKoiralaBArmstrongD, et al.Predictors of mortality and neurological morbidity in children undergoing extracorporeal life support for cardiac disease. Eur J Cardiothorac Surg. 2004;26(1):38-43.
30.
GuerraGGRobertsonCMAltonGY, et al.Health-related quality of life in pediatric cardiac extracorporeal life support survivors. Pediatr Crit Care Med. 2014;15(1):720-727.
31.
HomsyJZaidiSShenY, et al.De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. Science. 2015;350(6265):1262-1266.
32.
WoythalerM. Neurodevelopmental outcomes of the late preterm infant. Semin Fetal Neonatal Med. 2019;24(1):54-59.
33.
LongoSCaporaliCPisoniC, et al.Neurodevelopmental outcome of preterm very low birth weight infants admitted to an Italian tertiary center over an 11-year period. Sci Rep. 2021;11(1):16316.
34.
LimperopoulosCMajnemerAShevellMIRosenblattBRohlicekCTchervenkovC. Neurologic status of newborns with congenital heart defects before open heart surgery. Pediatrics. 1999;103(2):402-408.
35.
WilliamsIAFiferCJaeggiELevineJCMichelfelderECSzwastAL. The association of fetal cerebrovascular resistance with early neurodevelopment in single ventricle congenital heart disease. Am Heart J. 2013;165(4):544-550.
36.
LimperopoulosCTworetzkyWMcElhinneyDB, et al.Brain volume and metabolism in fetuses with congenital heart disease: Evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation. 2010;121(1):26-33.
37.
MillerSPMcQuillenPSHamrickS, et al.Abnormal brain development in newborns with congenital heart disease. N Engl J Med. 2007;357(19):1928-1938.
38.
PaquetteLBWisnowskiJLCeschinR, et al.Abnormal cerebral microstructure in premature neonates with congenital heart disease. Am J Neuroradiol. 2013;34(10):2026-2033.
39.
WolfMJKanterKRKirshbomPMKogonBEWagonerSF. Extracorporeal cardiopulmonary resuscitation for pediatric cardiac patients. Ann Thorac Surg. 2012;94(3):874-879.
40.
MortonPDIshibashiNJonasRA. Neurodevelopmental abnormalities and congenital heart disease: insights into altered brain maturation. Circ Res. 2017;120(6):960-977.
41.
LeonettiCBackSAGalloVIshibashiN. Cortical dysmaturation in congenital heart disease. Trends Neurosci. 2019;42(3):192-204.
42.
GalliKKZimmermanRAJarvikGP, et al.Periventricular leukomalacia is common after neonatal cardiac surgery. J Thorac Cardiovasc Surg. 2004;127(3):692-704.
43.
ChaturvediRRMacraeDBrownKL, et al.Cardiac ECMO for biventricular hearts after pediatric open heart surgery. Heart. 2004;90(5):545-551.
44.
GuptaPRobertsonMJRettigantiM, et al.Impact of timing of ECMO initiation on outcomes after pediatric heart surgery: a multi-institutional analysis. Pediatr Cardiol. 2016;37(5):971–978.
45.
KuraimGAGarrosDRyersonL, et al.Predictors and outcomes of early post-operative veno-arterial extracorporeal membrane oxygenation following infant cardiac surgery. J Intensive Care. 2018;6:56.
46.
PeekGJFirminRK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J. 1999;45(4):250-263.
47.
HirschJCJacobsMLAndropoulosD, et al.Protecting the infant brain during cardiac surgery: a systematic review. Ann Thorac Surg. 2012;94(4):1365-1373.
48.
StegemanRLamurKDvan den HoogenA, et al.Neuroprotective drugs in infants with severe congenital heart disease: a systematic review. Front Neurol. 2018;9:521.
49.
AlsoufiBShenIKaramlouT, et al.Extracorporeal life support in neonates, infants, and children after repair of congenital heart disease: modern era results in a single institution. Ann Thorac Surg. 2005;27:548-553.
50.
SyESklarMCLequierL, et al.Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care. 2017;39:87-96.
51.
Di NisioMMiddeldorpSBullerHR. Direct thrombin inhibitors. N Engl J Med. 2005;353(10):1028-1104.
52.
PieriMAgrachevaNBonaveglioE, et al.Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study. J Cardiothorac Vasc Anest. 2013;27(1):30-34.
53.
WypijDJonasRABellingerDC, et al.The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg. 2008;135(2):355-360.
54.
FieldDJuszczakELinsellL, et al.Neonatal ECMO study of temperature (NEST): a randomized controlled trial. Pediatrics. 2013;132(5):e1247-e1256.
55.
IjsselstijnHSchillerRMHolderC, et al.Extracorporeal life support organization (ELSO) guidelines for follow-up after neonatal and pediatric extracorporeal membrane oxygenation. ASAIO J. 2021;67(9):955-963.
56.
HaginoIAnttilaVZurakowskiDDuebenerLFLidovHGJonasRA. Tissue oxygenation index is a useful monitor of histologic and neurologic outcome after cardiopulmonary bypass in piglets. J Thorac Cardiovasc Surg. 2005;130(2):384-392.
57.
McQuillenPSBarkovichAJHamrickSE, et al.Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke. 2007;38(2Suppl):736-741.
58.
KobayashiKLiuCJonasRAIshibashiN. The current status of neuroprotection in congenital heart disease. Children (Basel). 2021;8(12):1116.
59.
MartinelloKASheperdEMiddletonP, et al.Allopurinol for women in pregnancy for neuroprotection of the fetus. Cochrane Database Syst Rev. 2017;2017(12):CD012881.
60.
ChenQYuWShiJ, et al.The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model. J Cardiothorac Surg. 2013;8:186.
61.
PastuszkoPSchearsGKubinJ, et al.The apoptotic and inflammatory response of brain striatal tissue to ECMO following the model of cardiac arrest in young piglets. World J Cardiovasc Dis. 2021;11(11):498-508.
62.
AndropoulosDBBradyKMEasleyRBFraser JrCD. Neuroprotection in pediatric cardiac surgery: what is on the horizon?Prog Pediatr Cardiol. 2010;29(2):113-122.
63.
MaedaTSarkislaliKLeonettiC, et al.Impact of mesenchymal stromal cell delivery through cardiopulmonary bypass on postnatal neurogenesis. Ann Thorac Surg. 2020;109(4):1274-1281.
64.
SleeperLAAlexanderPKellyDP, et al.Design and execution challenges of the multicenter TITRE trial of indication-based red blood cell transfusion in pediatric ECMO. J Heart Lung Transplant. 2023;42(4 Suppl):S481.
65.
MonteleoneMSalorioC. Lessons learned in neurodevelopmental outcomes research in children following extracorporeal membrane oxygenation. J of Neurosurg Anesthesiol. 2023;35(1):124-126.
66.
ShouBLOngCSZhouAL, et al.Arterial carbon dioxide and acute brain injury in venoarterial extracorporeal membrane oxygenation. ASAIO J. 2022;68(12):1501-1507.
67.
AkbarAFShouBLFengCY, et al.Lower oxygen tension and intracranial hemorrhage in veno-venous extracorporeal membrane oxygenation. Lung. 2023;201(3):315-320.
68.
IjsselstijnHvan HeijstAF. Long-term outcome of children treated with neonatal extracorporeal membrane oxygenation: increasing problems with increasing age. Semin Perinatol. 2014;38(2):114-121.
